http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012233057-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639cde93ad25c4794ecf02278c933fa2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64202ed72c871e854cd8b50e67ef410 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fb1614fd0e5d89624c7ea3dacb9504 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3281459be3eb624dfd8cd15b1dced85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b7225aaeae98f17269a4d36a29a277 |
| publicationDate | 2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2012233057-A1 |
| titleOfInvention | Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| abstract | Abstract According to the invention, tumour-associated gene 5 products and nucleic acids coding therefor were identified. The present invention relates to the therapy and diagnosis of diseases wherein said tumour-associated gene products are expressed aberrantly. The invention also relates to 10 proteins, polypeptides and peptides which are expressed in a tumour-associated manner and the nucleic acids coding therefor. ,1000 ~10 0 ---- ------ _- 0 ,-, ,,, Gewebe A ACTIVATION X D TESTICLE 8 SVQN E TISSUE |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115641912-A |
| priorityDate | 2003-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 304.